Strong provider-education program with CE-accredited training on peptide therapy for clinicians
Trial REDEFINE 2 Phase 3 Duration 68 weeks Population (N) 1,206 adults with T2D + obesity/overweight Key Result 13.7% mean weight change vs 3.4% placebo (treatment-policy)
If you have underlying health conditions or take medication, you should have a full evaluation before starting therapy
Retatrutide is becoming the focus for studies that require aggressive lipid clearance, extreme metabolic stabilization, or investigations into thermogenesis and energy balance
What if there was something that could have a much more dramatic effect on aging at the cellular level, that takes less time and effort, and in many cases is more cost-effective
AHK-Cu has gained attention within peptide haircare and scalp serum formulations, making it an increasingly popular ingredient in modern scalp-focused products